Pay in 4 interest-free payments of $36.25 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
SHP099 suppresses RAS–ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro and is efficacious in mouse tumour xenograft models
1004359-67-4 Molecular Formula C38H34N8O5 Molecular Weight 682
92 SMILES: CC1(C)\C(=C/C=C/C2=[N+](CCCCCC(=O)NCC#C)C3=CC=C(C=C3C2(C)C)S(O)(=O)=O)N(CCCS([O-])(=O)=O)C2=CC=C(C=C12)S(O)(=O)=O Purity (HPLC): ≥ 95% Shipping Conditions: room temperature Storage Conditions: Refrigerated Regulatory Statement: For Research Use Only
It contains an BODIPY moeity connected to Trametiglue scaffold
Product Name Lenalidomide-PEG5-propargyl Synonyms Lenalidomide-4'-PEG5-propargyl CAS Number n/a Related CAS Molecular Formula C26H35N3O8 Molecular Weight 517
CA-DOTA-tris(t-Bu) AHPC SHP099 suppresses RAS–ERK signalling toHaloTag is a self labeling protein derived from the haloalkane dehalogenase DhaA from Rhodococcus rhodochrous. Its active site reacts with chloroalkane substrates to form an irreversible bond. The covalent linkage between the HaloTag ligand and HaloTag protein enables rapid isolation and purification. CA DOTA tris(t Bu) can be used to attach DOTA moiety to protein. DOTA has been used in many different diagnostic and therapeutic applications, such as
